From BioHealth Investor
Biotechnology
ANTIGENICS INC [AGEN] +11.46%
CADENCE PHARM. INC. [CADX] +10.04%
COMBINATORX [CRXX] +9.53%
GENITOPE CORPORATION [GTOP] +9.24%
PROGEN INDS LTD [PGLA] +8.84%
Diagnostic Substances
ICAGEN, INC. [ICGN] +11.11%
LEXICON GENETICS I [LEXG] +8.44%
ISTA PHARMACTLS [ISTA] +6.97%
SYNTA PHARMACEUTICAL [SNTA] +6.71%
CYTOGEN CORP [CYTO] +4.76%
Drug Delivery
COLUMBIA LABS INC [CBRX] +8.04%
DELCATH SYSTEMS INC [DCTH] +6.73%
MATRIXX INITIATVS [MTXX] +6.49%
BIOPROGRESS PLC [BPRG] +3.78%
NOVADEL PHARMA INC [NVD] +3.76%
Drug Manufacturers
SANTARUS, INC. [SNTS] +18.49%
YM BIOSCIENCES INC [YMI] +15.38%
INTERPHARM HLDGS INC [IPA] +12.12%
CARDIOME PHARMA NEW [CRME] +10.38%
POZEN INC [POZN] +10.25%
Medical Appliances & Equipment
SYNERGETICS USA INC [SURG] +8.89%
BSD MEDICAL CORP [BSM] +8.21%
UROLOGIX INC [ULGX] +8.08%
ENDOCARE INC [ENDO.OB] +6.38%
CRITICARE SYS INC [CMD] +6.06%
Medical Instruments & Supplies
ROCHESTER MEDICAL [ROCM] +16.26%
EP MEDSYSTEMS INC [EPMD] +8.33%
DEXCOM [DXCM] +7.23%
HEMOSENSE INC. [HEM] +6.34%
CAS MEDICAL SYS INC [CASM] +5.81%
Medical Laboratories & Research
MEDASORB TECHNOLOGS [MSBT.OB] +20.00%
ERESEARCHTECHNOLOG [ERES] +5.41%
GENOMIC HEALTH, INC. [GHDX] +5.37%
ALLIANCE IMAGING INC [AIQ] +4.87%
AETERNA ZENTARIS [AEZS] +3.75%
http://www.biohealthinvestor.com/
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
